CTRI/2021/07/035307进行中（未招募）未知
Effect Of Discontinuation of Methotrexate, post 2nd dose on Immunogenicity Of ChAdOx1 nCoV -19 Corona Virus (COVISHIELD)Vaccination in Patients With Autoimmune Rheumatic diseases who continued their Methotrexate doses after 1st dose : A Single Centre Randomized Clinical Trial
Centre for Arthritis and Rheumatism Excellence CARE0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion Criteria
- •Patient above 18 years of age.
- •Patients willing to give consent for the study
- •Patients with a prior diagnosis of Autoimmune Rheumatic Disease and on methotrexate ,
- •stable dose for atleast the past 2 months
排除标准
- •Patients who had covid-19 infection in the past.
- •Patients who are not willing for blood sample collection.
- •Patients with h/o allergy to vaccine components Prior GBS/demyelinating syndromes
- •Any live vaccine taken within prior 4 weeks or inactivated vaccine in last 2 weeks before study.
研究者
相似试验
进行中（未招募）
不适用
To understand the immunogenicity of Covisheild vaccine in patients with RA by discontinuing methotrexate temporarilyCTRI/2021/07/034639Centre for Arthritis and Rheumatism Excellence CARE
Unknown
不适用
2-week dc of MTX and Influenza Vaccination in RAMethotrexateInfluenzaRheumatoid ArthritisNCT02897011Seoul National University Hospital318
已完成
4 期
MTX Discontinuation and Vaccine ResponseArthritis, RheumatoidNCT02748785Seoul National University Hospital277
已完成
不适用
Tapering and withdrawal of methotrexate and biologics in patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000018848Keio University Hospital900
已完成
4 期
Tapering and withdrawal of Methotrexate(MTX) or Tocilizumab(TCZ), after achievement of RA remission in concomitant use of MTX and TCZ,a randomized control study.rheumatoid arthritisJPRN-UMIN000017577Keio University60